AllAsclepix Therapeutics AsclepiX Therapeutics Announces $35 Million Series A Financing Proceeds to fund development of AXT107 for treatment of retinal diseases through Phase 1/2a clinical…skylarbennethumJune 24, 2020
AllCereno Scientific Cereno Scientific enters collaboration with University of Michigan TUE, JUN 09, 2020 08:40 CET Cereno Scientific today announced that the company enters a…skylarbennethumJune 9, 2020
AllNexImmune NexImmune to Present at the Jefferies Virtual Healthcare Conference GAITHERSBURG, MD – June 1, 2020 – NexImmune, a clinical-stage biopharma company advancing a new generation…dantetzlJune 1, 2020
AllCereno Scientific The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the first quarter 2020 The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim…dantetzlMay 14, 2020
AllCereno Scientific Cereno Scientific announces US subsidiary in Cambridge, Boston, MA Cereno Scientific develops innovative medicines for cardiovascular and rare diseases related to fibrosis, thrombosis, inflammation…dantetzlMay 13, 2020
AllCereno Scientific Cereno Scientific adds a clinical expert to its ODD track Cereno Scientific develops innovative drugs for cardiovascular diseases, with a broadened focus on thrombosis and rare…dantetzlApril 2, 2020